News for MBII Stock

Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp. Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time Marrone Bio Announces CFO Transition Marrone Bio and Corteva Agriscience Announce New Distribution Contract Marrone Bio Innovations Issues Shareholder Letter Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warrant Overhang Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹ Marrone Bio’s Next-Generation Product for Environmentally Sustainable Pest Control Demonstrates Substantial Yield Gains in 2021 Field Trials Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Results Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil Marrone Bio Innovations to Report Third Quarter 2021 Results on Wednesday, November 10 at 4:30 p.m. Eastern Time Marrone Bio Advances Novel Herbicides Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results Marrone Bio Innovations Collaborates with Terramera to Enhance Product Performance and Expedite Novel Product Development Marrone Bio Innovations to Report Second Quarter 2021 Results on Monday, August 16 at 4:30 p.m. Eastern Time Rizobacter and Marrone Bio Innovations Expand Strategic Alliance to Supply Novel Seed Treatment in Brazil Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus® Biofungicide in Canada Marrone Bio Innovations Issues Shareholder Letter Marrone Bio Innovations, Inc. Reports First-Quarter 2021 Financial Results BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pesticides Marrone Bio Innovations to Report First Quarter 2021 Results on Thursday, May 13th at 4:30 p.m. Eastern Time Marrone Bio Innovations Issues Shareholder Letter Marrone Bio Innovations Joins United Nations Global Compact & Launches Environmental, Social & Governance Initiative Marrone Bio Innovations Issues Shareholder Letter Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2020 Financial Results Marrone Bio Innovations to Report Fourth Quarter and Full Year 2020 Results on Tuesday, March 23rd at 4:30 p.m. Eastern Time Marrone Bio Innovations’ New Plant Health Product, Pacesetter®, Delivers a Six to One Return on Investment for Corn and Soybean Farmers Marrone Bio Files $90 Million Shelf Registration Statement Marrone Bio Innovations Issues Shareholder Letter Marrone Bio Appoints Sue Cheung New Chief Financial Officer Global Adoption of Biologicals Accelerates as Marrone Bio’s Grandevo® WDG Bioinsecticide is Approved for Use in New Zealand, Chile and on Hemp in the U.S. Marrone Bio Innovations Announces Effectiveness of Form S-3 Resale Registration Statement Marrone Bio Provides Update on Warrant Transactions; No New Securities Offered PGG Wrightson Seeds to Distribute Marrone Bio Innovations’ Pro Farm UBP Seed Treatment in Uruguay Marrone Bio Innovations, Inc. Reports Third-Quarter 2020 Financial Results Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors Marrone Bio Innovations to Report Third Quarter 2020 Results on Monday, November 9th at 4:30 p.m. Eastern Time Marrone Bio Innovations Issues Shareholder Letter and Provides Operational Update Marrone Bio Innovations Announces Plans for CFO Succession Rizobacter and Marrone Bio Innovations form a Strategic Alliance to Deploy Novel Plant Health and Crop Nutrition Technology in South America Marrone Bio Innovations to Present at H.C. Wainwright 22nd Annual Global Investment Conference Marrone Bio Innovations to Present at LD Micro 500 Virtual Investor Conference Vive Crop Protection and Marrone Bio Innovations join forces to bring next-generation crop protection solutions to growers Marrone Bio Innovations’ REGALIA® MAXX Receives First Approval for Use on Cannabis and Hemp in Canada Marrone Bio Innovations to Report First Quarter 2020 Results on Monday, May 11th at 4:30 p.m. Eastern Time Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule Marrone Bio Innovations to Present at the Canaccord Genuity 40th Annual Growth Conference on August 12th Marrone Bio Appoints Kevin Helash as Chief Executive Officer Marrone Bio Innovations Regains Compliance with Nasdaq Minimum Bid Price Requirement Marrone Bio Innovations to Present at the June 2020 Virtual Investor Summit Marrone Bio Innovations, Inc. Reports First Quarter 2020 Financial Results Marrone Bio Announces Warrant Exchange Agreement Marrone Bio Innovations to Report Second Quarter 2020 Results on Monday, August 10th at 4:30 p.m. Eastern Time Marrone Bio Innovations’ Regalia® is Top Biofungicide Brand in California Marrone Bio Innovations and UPL Sign Exclusive Distribution Agreement for REGALIA® MAXX in the Republic of South Africa